- Report
- March 2024
- 146 Pages
Global
From €2867EUR$2,999USD£2,464GBP
- Report
- May 2024
- 188 Pages
Global
From €3226EUR$3,374USD£2,772GBP
€3584EUR$3,749USD£3,080GBP
- Report
- May 2024
- 89 Pages
Global
From €5354EUR$5,600USD£4,601GBP
- Report
- February 2024
- 120 Pages
Global
From €4541EUR$4,750USD£3,902GBP
- Report
- October 2021
- 190 Pages
Denmark, Estonia, ... Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, Sweden, Europe
From €2510EUR$2,625USD£2,157GBP
- Report
- May 2021
- 216 Pages
Global
From €5019EUR$5,250USD£4,313GBP
- Report
- April 2024
- 183 Pages
From €4684EUR$4,900USD£4,026GBP
- Report
- March 2023
- 113 Pages
Global
From €4684EUR$4,900USD£4,026GBP
The Reproductive Genetics market is a subset of the Genomics market that focuses on the study of genetic information related to reproduction. It includes the analysis of genetic material from gametes, embryos, and fetuses, as well as the use of genetic testing to identify potential risks to reproductive health. This market is driven by the increasing demand for pre-implantation genetic diagnosis (PGD) and pre-natal screening, as well as the development of new technologies such as next-generation sequencing (NGS).
The Reproductive Genetics market is expected to experience strong growth in the coming years, driven by the increasing prevalence of genetic disorders, the growing demand for personalized medicine, and the development of new technologies.
Some companies in the Reproductive Genetics market include Illumina, Thermo Fisher Scientific, BGI, and Natera. Show Less Read more